Liquid Biopsy: A New Translational Diagnostic and Monitoring Tool for Musculoskeletal Tumors
Soft tissue and bone sarcomas represent a group of aggressive neoplasms often accompanied by dismal patient prognosis, especially when distant metastases are present. Moreover, effective treatment can pose a challenge, as recurrences are frequent and almost half of patients present with advanced dis...
Guardado en:
Autores principales: | Argyris C. Hadjimichael, Alexandros Pergaris, Angelos Kaspiris, Athanasios F. Foukas, Stamatios E. Theocharis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d790488bd526459ab57ce3d7d2a52854 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Accuracy and Safety of Ultrasound-Guided Core Needle Biopsy of Soft Tissue Tumors in an Outpatient Setting: A Sarcoma Center Analysis of 392 Consecutive Patients
por: Helene Weigl, et al.
Publicado: (2021) -
Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea—A Sarcoma-Specific, Institutional Registry-Based Analysis
por: Jeong H, et al.
Publicado: (2021) -
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
por: Eijiro Shimada, et al.
Publicado: (2021) -
Imaging and Pathological Features of Alveolar Soft Part Sarcoma: Analysis of 16 Patients
por: Malvika Gulati, et al.
Publicado: (2021) -
Establishment of A Nomogram for Predicting the Prognosis of Soft Tissue Sarcoma Based on Seven Glycolysis-Related Gene Risk Score
por: Yuhang Liu, et al.
Publicado: (2021)